These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 25218295

  • 1. Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7/L12 or Omp16 proteins: evaluation of protection in pregnant heifers.
    Tabynov K, Yespembetov B, Sansyzbay A.
    Vaccine; 2014 Oct 14; 32(45):5889-92. PubMed ID: 25218295
    [Abstract] [Full Text] [Related]

  • 2. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.
    Tabynov K, Kydyrbayev Z, Ryskeldinova S, Yespembetov B, Zinina N, Assanzhanova N, Kozhamkulov Y, Inkarbekov D, Gotskina T, Sansyzbay A.
    Vaccine; 2014 Apr 11; 32(18):2034-41. PubMed ID: 24598723
    [Abstract] [Full Text] [Related]

  • 3. Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection.
    Tabynov K, Yespembetov B, Ryskeldinova S, Zinina N, Kydyrbayev Z, Kozhamkulov Y, Inkarbekov D, Sansyzbay A.
    Vaccine; 2016 Jan 20; 34(4):438-444. PubMed ID: 26709638
    [Abstract] [Full Text] [Related]

  • 4. An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers.
    Tabynov K, Ryskeldinova S, Sansyzbay A.
    Vaccine; 2015 Jul 17; 33(31):3619-23. PubMed ID: 26093199
    [Abstract] [Full Text] [Related]

  • 5. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
    Tabynov K, Sansyzbay A, Kydyrbayev Z, Yespembetov B, Ryskeldinova S, Zinina N, Assanzhanova N, Sultankulova K, Sandybayev N, Khairullin B, Kuznetsova I, Ferko B, Egorov A.
    Virol J; 2014 Apr 10; 11():69. PubMed ID: 24716528
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous subcutaneous and conjunctival administration of the influenza viral vector based Brucella abortus vaccine to pregnant heifers provides better protection against B. abortus 544 infection than the commercial B. abortus S19 vaccine.
    Tabynov K, Orynbayev M, Renukaradhya GJ, Sansyzbay A.
    Vaccine; 2016 Sep 30; 34(42):5049-5052. PubMed ID: 27595898
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan 30; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

  • 9. Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle.
    Wyckoff JH, Howland JL, Scott CM, Smith RA, Confer AW.
    Vet Microbiol; 2005 Nov 30; 111(1-2):77-87. PubMed ID: 16242273
    [Abstract] [Full Text] [Related]

  • 10. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus.
    Cheville NF, Stevens MG, Jensen AE, Tatum FM, Halling SM.
    Am J Vet Res; 1993 Oct 30; 54(10):1591-7. PubMed ID: 8250382
    [Abstract] [Full Text] [Related]

  • 11. Registered Influenza Viral Vector Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies.
    Ryskeldinova S, Zinina N, Kydyrbayev Z, Yespembetov B, Kozhamkulov Y, Inkarbekov D, Assanzhanova N, Mailybayeva A, Bugybayeva D, Sarmykova M, Khairullin B, Tabynov K, Bulashev A, Aitzhanov B, Abeuov K, Sansyzbay A, Yespolov T, Renukaradhya GJ, Olsen S, Oñate A, Tabynov K.
    Front Cell Infect Microbiol; 2021 Oct 30; 11():669196. PubMed ID: 34290993
    [Abstract] [Full Text] [Related]

  • 12. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M, Rafati S, Siadat SD, Nejati-Moheimani M, Shahcheraghi F, Arsang A, Bouzari S.
    Mol Immunol; 2015 Aug 30; 66(2):384-91. PubMed ID: 25968974
    [Abstract] [Full Text] [Related]

  • 13. First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.
    Tabynov K, Yespembetov B, Matikhan N, Ryskeldinova S, Zinina N, Kydyrbayev Z, Assanzhanova N, Tabynov K, Renukaradhya GJ, Mukhitdinova G, Sansyzbay A.
    Vet Microbiol; 2016 Dec 25; 197():15-20. PubMed ID: 27938677
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protection of BALB/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide.
    Pakzad I, Rezaee A, Rasaee MJ, Hossieni AZ, Tabbaraee B, Kazemnejad A.
    Roum Arch Microbiol Immunol; 2010 Dec 25; 69(1):5-12. PubMed ID: 21053778
    [Abstract] [Full Text] [Related]

  • 18. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P, Surendran N, Seleem MN, Sriranganathan N, Schurig GG, Boyle SM.
    Vaccine; 2011 Apr 12; 29(17):3106-10. PubMed ID: 21376799
    [Abstract] [Full Text] [Related]

  • 19. The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis.
    Pasquevich KA, García Samartino C, Coria LM, Estein SM, Zwerdling A, Ibañez AE, Barrionuevo P, Oliveira FS, Carvalho NB, Borkowski J, Oliveira SC, Warzecha H, Giambartolomei GH, Cassataro J.
    J Immunol; 2010 May 01; 184(9):5200-12. PubMed ID: 20351187
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of strain RB51 vaccine in heifers against experimental brucellosis.
    Poester FP, Gonçalves VS, Paixão TA, Santos RL, Olsen SC, Schurig GG, Lage AP.
    Vaccine; 2006 Jun 19; 24(25):5327-34. PubMed ID: 16713034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.